4-chloro-6-methyl-5-(4-methylphenyl)thieno[2,3-d]pyrimidine, 95.0%, 500mg

L-N-Butylsulfonyl-p-hydroxyphenylalanine, 97.0%, 5g

iScope IS.1153-EPL/DF Triocular with E-plan objectives and Rackless cross table (dark field contrast application)

5-Hydroxypiperidine-3-carboxylic acid hydrochloride, 95.0%, 250mg

2-(6-BROMOHEXYL)OXIRANE, 95%, 25g

(3R)-7-CHLORO-2,3-DIHYDRO-1-BENZOFURAN-3-AMINE HYDROCHLORIDE, 95.0%, 100mg

6-Chloro-4-methylpyridin-2-amine, 95.0%, 25g

tert-Butyl 2-(3-methoxy-3-oxopropyl)pyrrolidine-1-carboxylate, 95%, 1g

ISOPROPYL 2,6-DICHLOROISONICOTINATE, 95.0%, 500mg

Ancitabine Hydrochloride>98.0%(HPLC)(N)5g

5-(tert-Butyl)pyridin-2-amine, 95%, 1g

(5R)-1-(tert-butoxycarbonyl)-5-methyl-D-proline, 95.0%, 500mg

4-(3-methylphenyl)butanoic acid, 95.0%, 500mg